WallStreetZenWallStreetZen
Analyst Ranking
Bottom 1%
#4484 out of 4527 analysts
Average Return
-9.74%
Win Rate
36%51 out of 140
Risk vs Reward
Poor
Good

Andrew Berens's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Forma Therapeutics Holdings IncFMTX
+246.79%$5.77$20.01
2022-05-27 -
2022-10-13
Buy
Turning Point Therapeutics IncTPTX
+191.29%$25.50$74.28
2022-05-11 -
2022-06-13
Buy
Global Blood Therapeutics IncGBT
+167.43%$24.90$66.59
2021-12-14 -
2022-08-09
Buy
Blueprint Medicines CorpBPMC
+130.14%$35.87$82.55
2017-02-15 -
2018-02-15
Strong Buy
Global Blood Therapeutics IncGBT
+113.84%$31.14$66.59
2021-12-21 -
2022-08-09
Buy

Andrew Berens Analyst Color

Get additional color on Andrew Berens's coverage of popular stocks

Andrew Berens's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Incyte CorpINCY
12Buy$78.00+36.55%Upgrades
4 months ago
Mirati Therapeutics IncMRTX
7Hold$58.00-1.19%Downgrades
5 months ago
Viracta Therapeutics IncVIRX
4Buy$5.00+362.96%Maintains
7 months ago
Blueprint Medicines CorpBPMC
16Sell$43.00-54.64%Downgrades
10 months ago
Elevation Oncology IncELEV
4Buy$8.00+59.68%Upgrades
10 months ago
Cti Biopharma CorpCTIC
2Hold$9.10+0.11%Downgrades
10 months ago
Merus NvMRUS
5Buy$48.00+7.26%Maintains
a year ago
Deciphera Pharmaceuticals IncDCPH
8Buy$30.00N/AReiterates
a year ago
Seagen IncSGEN
19Hold$141.00N/ADowngrades
a year ago
Beigene LtdBGNE
9Buy$300.00N/AMaintains
a year ago
Zymeworks IncZYME
9Hold$10.00N/AMaintains
a year ago
Cogent Biosciences IncCOGT
4Buy$20.00N/AMaintains
a year ago
Nurix Therapeutics IncNRIX
3Buy$28.00N/AMaintains
a year ago
Arvinas IncARVN
5Buy$70.00N/AMaintains
a year ago
Astrazeneca PLCAZN
10Buy$79.00N/AMaintains
a year ago
Zentalis Pharmaceuticals IncZNTL
7Buy$27.00N/AMaintains
a year ago
Aveo Pharmaceuticals IncAVEO
3HoldN/AN/ADowngrades
a year ago
Hookipa Pharma IncHOOK
3Buy$3.00N/AMaintains
2 years ago
Global Blood Therapeutics IncGBT
4Hold$68.50N/ADowngrades
2 years ago
Agios Pharmaceuticals IncAGIO
8Buy$37.00N/AMaintains
2 years ago
Turning Point Therapeutics IncTPTX
5Hold$76.00N/ADowngrades
2 years ago
Forma Therapeutics Holdings IncFMTX
5Buy$23.00N/AMaintains
2 years ago
Cullinan Oncology IncCGEM
3Buy$25.00N/AMaintains
2 years ago
Compass Therapeutics IncCMPX
2Buy$11.00N/AMaintains
2 years ago
Aura Biosciences IncAURA
1Buy$40.00N/AInitiates Coverage On
2 years ago
Theseus Pharmaceuticals IncTHRX
1Buy$28.00N/AInitiates Coverage On
2 years ago
C4 Therapeutics IncCCCC
1Buy$67.00N/AInitiates Coverage On
2 years ago
Monte Rosa Therapeutics IncGLUE
1Hold$20.00N/AInitiates Coverage On
2 years ago
Tango Therapeutics IncTNGX
1Buy$25.00N/AInitiates Coverage On
3 years ago
Epizyme IncEPZM
4Buy$16.00N/AUpgrades
3 years ago
Clovis Oncology IncCLVSQ
2Sell$5.00N/ADowngrades
4 years ago
Nabriva Therapeutics PLCNBRVF
2Strong Buy$2,000.00N/AReinstates
6 years ago
Tesaro IncTSRO
2Strong Buy$146.00N/AMaintains
6 years ago
Intercept Pharmaceuticals IncICPT
1Strong Sell$50.00N/AMaintains
7 years ago
Ocular Therapeutix IncOCUL
2Hold$8.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.